KRYS logo

KRYS
Krystal Biotech Inc

1,729
Mkt Cap
$6.44B
Volume
65,212.00
52W High
$222.66
52W Low
$122.80
PE Ratio
33.29
KRYS Fundamentals
Price
$226.05
Prev Close
$221.96
Open
$221.66
50D MA
$195.45
Beta
0.92
Avg. Volume
311,934.11
EPS (Annual)
$3.00
P/B
5.65
Rev/Employee
$1.06M
Loading...
Loading...
News
all
press releases
Edgestream Partners L.P. Buys Shares of 19,678 Krystal Biotech, Inc. $KRYS
Edgestream Partners L.P. purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the second quarter, according to its most recent filing with the Securities and...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
read more...
Benzinga·20h ago
News Placeholder
Segall Bryant & Hamill LLC Boosts Holdings in Krystal Biotech, Inc. $KRYS
Segall Bryant & Hamill LLC raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.3% in the second quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·11d ago
News Placeholder
Cynosure Group LLC Acquires 2,016 Shares of Krystal Biotech, Inc. $KRYS
Cynosure Group LLC boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 51.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·11d ago
News Placeholder
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) have received an average rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat Ratings...
MarketBeat·12d ago
News Placeholder
Krystal Biotech (NASDAQ:KRYS) Reaches New 1-Year High - Should You Buy?
Krystal Biotech (NASDAQ:KRYS) Reaches New 52-Week High - Still a Buy...
MarketBeat·13d ago
News Placeholder
Envestnet Asset Management Inc. Acquires 2,717 Shares of Krystal Biotech, Inc. $KRYS
Envestnet Asset Management Inc. raised its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 21.9% in the second quarter, according to the company in its most recent filing...
MarketBeat·17d ago
News Placeholder
M&G PLC Takes Position in Krystal Biotech, Inc. $KRYS
M&G PLC acquired a new position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·20d ago
News Placeholder
Profund Advisors LLC Acquires 2,203 Shares of Krystal Biotech, Inc. $KRYS
Profund Advisors LLC boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 36.9% during the second quarter, according to the company in its most recent disclosure...
MarketBeat·22d ago
News Placeholder
Krystal Biotech, Inc. $KRYS Shares Bought by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC increased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 6.9% during the second quarter, according to its most recent filing with the...
MarketBeat·23d ago

Latest KRYS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.